DengiAll: India’s First Indigenous Dengue Vaccine In Final Trials. When Will It Hit The Market?

India’s first indigenous dengue vaccine, ‘DengiAll’, developed by ICMR and Panacea Biotech, is in Phase 3 trials and may be available by mid-2026, says former ICMR Director Balram Bhargava

Leave a Reply

Your email address will not be published. Required fields are marked *